The U.S. blood ketone meter market size was estimated at USD 106.1 million in 2024 and is projected to reach USD 115.1 million by 2033, growing at a CAGR of 0.9% from 2025 to 2033. Some of the factors contributing to market growth include the increasing prevalence of diabetes, growing health awareness among consumers and rising adoption of ketogenic and low-carbohydrate diets.
The growth is driven by increasing interest in metabolic health management, particularly within the keto diet community and among people who need to monitor Blood ketone meters are used to monitor ketone levels for managing Type 1 Diabetes (T1D), tracking nutritional ketosis in ketogenic diets, and supporting the treatment of neurological conditions such as epilepsy. A 2023 study titled “Point-of-Care Capillary Blood Ketone Measurements and the Prediction of Future Ketoacidosis Risk in Type 1 Diabetes” investigated whether routine point-of-care capillary blood ketone measurements in fasted, symptom-free individuals with T1D could predict future DKA events.
The findings showed that routine capillary ketone monitoring can help identify individuals at elevated risk of future DKA, highlighting the potential value of emerging technologies such as Continuous Ketone Monitoring (CKM) for early intervention and prevention. With the growing awareness of DKAprevention, such evidence will likely broaden the adoption and expansion of the U.S. blood ketone meter market.
The U.S. blood ketone meter industry is shaped by evolving care delivery models and payer policy reforms. The rise of telehealth, boosted significantly by the COVID-19 pandemic, has made diabetes management more accessible by enabling remote consultations, real-time data sharing, and timely treatment adjustments. This shift supports more consistent use of monitoring tools such as blood ketone meters, especially for patients managing T1D or adhering to ketogenic therapies. In 2024, approximately 20,000 children and adolescents under the age of 20 in the U.S. were newly diagnosed with T1D. This increase is driven by inherited risk, environmental factors, and changes in early-life habits (such as diet and infections).
The MDPI 2025 study titled “Severe Diabetic Ketoacidosis in Children with Type 1 Diabetes” highlighted key findings on ketone monitoring. The study found that blood ketone testing was more effective than urine ketone testing in early DKA detection and management.
This product will be delivered within 2 business days.
The growth is driven by increasing interest in metabolic health management, particularly within the keto diet community and among people who need to monitor Blood ketone meters are used to monitor ketone levels for managing Type 1 Diabetes (T1D), tracking nutritional ketosis in ketogenic diets, and supporting the treatment of neurological conditions such as epilepsy. A 2023 study titled “Point-of-Care Capillary Blood Ketone Measurements and the Prediction of Future Ketoacidosis Risk in Type 1 Diabetes” investigated whether routine point-of-care capillary blood ketone measurements in fasted, symptom-free individuals with T1D could predict future DKA events.
The findings showed that routine capillary ketone monitoring can help identify individuals at elevated risk of future DKA, highlighting the potential value of emerging technologies such as Continuous Ketone Monitoring (CKM) for early intervention and prevention. With the growing awareness of DKAprevention, such evidence will likely broaden the adoption and expansion of the U.S. blood ketone meter market.
The U.S. blood ketone meter industry is shaped by evolving care delivery models and payer policy reforms. The rise of telehealth, boosted significantly by the COVID-19 pandemic, has made diabetes management more accessible by enabling remote consultations, real-time data sharing, and timely treatment adjustments. This shift supports more consistent use of monitoring tools such as blood ketone meters, especially for patients managing T1D or adhering to ketogenic therapies. In 2024, approximately 20,000 children and adolescents under the age of 20 in the U.S. were newly diagnosed with T1D. This increase is driven by inherited risk, environmental factors, and changes in early-life habits (such as diet and infections).
The MDPI 2025 study titled “Severe Diabetic Ketoacidosis in Children with Type 1 Diabetes” highlighted key findings on ketone monitoring. The study found that blood ketone testing was more effective than urine ketone testing in early DKA detection and management.
U.S. Blood Ketone Meter Market Report Segmentation
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. blood ketone meter market report based on type, application, and end use:Type Outlook (Revenue, USD Million, 2021 - 2033)
- Blood Ketone Monitoring
- Blood Glucose and Ketone Monitoring
- Consumables
Application Outlook (Revenue, USD Million, 2021 - 2033)
- Humans
- Veterinary
End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Diagnostic Centers
- Home Care Settings
- Other
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Blood Ketone Meter Market Variables, Trends & Scope
Chapter 4. U.S. Blood Ketone Meter Market: Type Estimates & Trend Analysis
Chapter 5. U.S. Blood Ketone Meter Market: Application Estimates & Trend Analysis
Chapter 6. U.S. Blood Ketone Meter Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Abbott
- Apex Biotechnology Corp.
- TaiDoc Technology Corporation
- EKF Diagnostics Holdings plc.
- Nova Biomedical
- Keto-Mojo
- ForaCare, Inc.
- Nipro
- i-SENS, Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | July 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 106.1 Million |
| Forecasted Market Value ( USD | $ 115.1 Million |
| Compound Annual Growth Rate | 0.9% |
| Regions Covered | United States |
| No. of Companies Mentioned | 9 |
